For months, a woman in rural Rwanda has struggled with a persistent cough. Her local clinic, hours from a major hospital, lacks a specialist. But a new pilot program changes her visit. She sits before a tablet, answering questions guided by an AI assistant in her local language. The system analyzes her speech and symptoms. It then flags her case for immediate human review. This connection could expedite her diagnosis dramatically. Yet, the tool itself was built thousands of miles away, trained on data that may not fully represent her community. Its arrival prompts a critical question: is this a lifeline, or does it simply automate an old inequity?
This tension lies at the heart of the global conversation about artificial intelligence in medicine. This spring, experts from Harvard Global Health Institute and Harvard Medical School’s Center for Bioethics convened to dissect this very puzzle. Their central finding was clear. AI’s ultimate impact won’t be decided by its raw technical power. It will be shaped by the human systems of governance, partnership, and implementation that guide it. Louise Ivers, HGHI’s faculty director, put it bluntly. “We must break the cycle of a lack of accountability,” she said. The race is to balance rapid adoption with the rigorous safeguards needed to ensure these tools are safe, effective, and truly serve the people they’re meant to help.
A major hurdle is that governance is constantly playing catch-up. National strategies and global frameworks, like UNESCO’s 2021 ethics recommendation, are essential. They call for AI grounded in human rights and fairness. But rules often arrive after the technology is already in use. The real challenge is moving from shared principles to local action. This demands institutional capacity and deep local expertise. Gabriela Ramos of UNESCO stressed this shift. The goal, she argued, is to ensure countries are not mere recipients of technology. They must be active participants in shaping it. “Getting the conversation back to the realities of the Global South is important,” Ramos noted. Each country has specific needs. They must define what capacities they need to build to understand and steer these powerful tools.
- National strategies for AI deployment
- Global frameworks promoting fairness
- Active participation from local countries
- Institutional capacity building
- Partnerships between tech companies and governments
- Alignment with national priorities
The partnerships formed to deploy AI are equally critical, and far from neutral. Collaborations between tech companies, philanthropies, and governments are booming. Yet they are deeply shaped by questions of power and ownership. Model development remains concentrated in a few high-income nations. Many deployment settings risk becoming markets for consumption, not equal co-creators. This raises fundamental issues. Who gets to define the health problems AI should solve? Whose expertise informs the design? Esther Kunda, of Rwanda’s Ministry of ICT and Innovation, highlighted her country’s different path. Rwanda is working to align AI with national priorities through its own policy. This represents a broader shift. It moves countries from being passive adopters to active architects of their technological future.
However, this path requires sober realism. Chinasa T. Okolo, an AI governance researcher, cautions that enthusiasm must be grounded. Investment in shiny new AI systems cannot come at the expense of hospitals, supply chains, and health workers. These form the bedrock of any resilient health system. The ecosystems across the Global South must be strengthened. They cannot be made permanently dependent on external providers.
| AI Benefits | Challenges |
|---|---|
| Faster diagnostics | Lack of local representation |
| Streamlined logistics | Governance issues |
| Personalized care | Risk of dependency |
| Global health equity | Limited local expertise |
| Improved health outcomes | Concentration of power |
| Enhanced data analysis | Technology adoption disparity |
The promise of AI in global health is undeniable. It offers tools for faster diagnostics, streamlined logistics, and personalized care. But its legacy will be written not in lines of code, but in the choices we make today. Will we build systems that amplify local voices and address specific needs? Or will we simply layer a new, digital divide onto old, structural ones? The patient in Rwanda awaits the answer.
